Furosemide Injection, Solution
Product Images NDC 25021-320

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Furosemide (NDC 25021-320). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Fur0b 0000 01)

Structural Formula (Fur0b 0000 01)
This is a chemical formula for a compound containing carbon, hydrogen, chlorine, nitrogen, oxygen, and sulfur elements. The molecular formula is C12H11ClN2O2S, with a molecular weight of 330.74 g/mol. The presence of functional groups like carboxylic acid (COOH) and amine (NH2) suggests potential reactivity or solubility properties.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Fur0b 0000 02)

Package Label – Principal Display Panel – Vial Label (Fur0b 0000 02)
This text provides information about a medication with the NDC code 25021-320-02, which is Furosemide Injection, USP containing 10 mg per mL in a 2 mL Single-Dose Vial. The warning indicates to discard the unused portion and use only if necessary. The direction for use advises referring to the prescribing information and storing between 20°C to 25°C to protect from light. The medication is manufactured for SAGENT Pharmaceuticals, located in Schaumburg, IL, USA, but made in India.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Fur0b 0000 03)

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Fur0b 0000 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.